Le Lézard
Classified in: Health, Science and technology
Subject: PLW

AiViva Biopharma Receives New Patent


NEWPORT BEACH, Calif., Aug. 17, 2022 /PRNewswire/ -- AiViva Biopharma, a clinical stage biopharmaceutical company has received patent US 11,400,089 on August 2, 2022. This patent is a method of use patent for sGC stimulator and multikinase inhibitors to prevent and/or treat fibrosis (thickening or scarring of tissue) associated with reproductive or digestive tract diseases. Fibrosis is involved in the pathogenesis of a number of diseases and/or disorders affecting the reproductive and digestive tracts in humans.

This patent adds to AiViva's 22 approved patents in the US, Canada, China, Japan, Korea, Australia, and Taiwan. To date, AiViva has filed over 63 patent applications worldwide.

"With these patents and proof of concept studies, it continues to secure our corporate position and development strategy to develop focal therapies for many diseases of significant unmet medical needs." said Diane Tang-Liu, PhD, CEO, President & Co-Founder.

About AiViva Biopharma

Please follow us at www.aiviva.com AiViva is a clinical stage biopharmaceutical company founded in 2015, with headquarters in Newport Beach, CA. AiViva is developing new therapeutics using innovative approaches, with proprietary technologies, including JELTM to address high unmet medical needs through focal therapies that target diseases of neovascularization, abnormal cell proliferation, and fibrosis.

SOURCE AiViva Biopharma


These press releases may also interest you

at 22:34
Flash News: OKX Partners with OverProtocol to Launch Airdrop Event on Cryptopedia
OKX, a leading Web3 technology company, has issued updates for April 17, 2024. OKX Partners with OverProtocol to Launch Airdrop Event...

at 21:57
Serve Robotics Inc. Announces Pricing of $40 Million Public Offering and Uplisting to the Nasdaq Capital Market Under New Ticker "SERV"
Serve Robotics Inc. (the "Company" or "Serve"), a leading autonomous sidewalk delivery company, today announced the pricing of its underwritten public offering of 10,000,000 shares of common stock at a price to the public of $4.00 per share, for...

at 21:05
Yugabyte Embraces ?No Downtime, No Limits,' as the Theme of the Upcoming Distributed SQL Summit Asia
Yugabyte, the leading open source distributed SQL database company, today announced the keynote theme and final schedule for the upcoming fourth annual Distributed SQL Summit (DSS) Asia. This year's virtual summit, taking place on Wednesday, April...

at 21:05
Microsoft Cloud Growth Speeds Up in Singapore, Malaysia
Companies in Singapore and Malaysia are accelerating their adoption of Microsoft cloud platforms as their efforts to improve customer and employee experience mature, according to a new research report published today by Information Services Group...

at 21:00
COSRX Ignites TikTok with #PatThePeptide Challenge Campaign
COSRX, the go-to skincare brand among dermatologists, has set TikTok ablaze with its latest social media sensation - the #PatThePeptide TikTok challenge. Running from March 7th to the 20th, the #PatThePeptide TikTok Challenge has captured the...

at 21:00
DataTracks Celebrates Completion of 19 Years
DataTracks, a provider of cloud-based software to automate/generate compliance reports for filing with financial/security regulators to more than 28,000 business enterprises in 26 countries, celebrates the completion of 19 years of service and...

More news about Science and technology...


News published on and distributed by: